Geneos Wealth Management’s Vanguard Short-Term Bond ETF BSV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.94M | Buy |
37,741
+519
| +1% | +$40.5K | 0.06% | 318 |
|
|
2026
Q1 | $2.92M | Buy |
37,222
+500
| +1% | +$39.4K | 0.07% | 301 |
|
|
2025
Q4 | $2.89M | Buy |
36,722
+1,396
| +4% | +$110K | 0.07% | 295 |
|
|
2025
Q3 | $2.79M | Buy |
35,326
+7,064
| +25% | +$555K | 0.07% | 293 |
|
|
2025
Q2 | $2.22M | Sell |
28,262
-100,522
| -78% | -$7.86M | 0.05% | 352 |
|
|
2025
Q1 | $10.1M | Buy |
128,784
+94,047
| +271% | +$7.3M | 0.15% | 170 |
|
|
2024
Q4 | $2.68M | Sell |
34,737
-1,688
| -5% | -$131K | 0.09% | 241 |
|
|
2024
Q3 | $2.87M | Buy |
36,425
+7,603
| +26% | +$592K | 0.11% | 218 |
|
|
2024
Q2 | $2.21M | Sell |
28,822
-538
| -2% | -$41K | 0.1% | 238 |
|
|
2024
Q1 | $2.25M | Buy |
29,360
+3,550
| +14% | +$272K | 0.1% | 229 |
|
|
2023
Q4 | $1.99M | Sell |
25,810
-4,056
| -14% | -$307K | 0.1% | 230 |
|
|
2023
Q3 | $2.25M | Buy |
29,866
+8,411
| +39% | +$634K | 0.12% | 199 |
|
|
2023
Q2 | $1.62M | Buy |
21,455
+9,753
| +83% | +$743K | 0.08% | 238 |
|
|
2023
Q1 | $895K | Buy |
11,702
+7,403
| +172% | +$561K | 0.05% | 316 |
|
|
2022
Q4 | $324K | Sell |
4,299
-655
| -13% | -$49.1K | 0.02% | 503 |
|
|
2022
Q3 | $370K | Sell |
4,954
-7,176
| -59% | -$548K | 0.03% | 449 |
|
|
2022
Q2 | $934K | Sell |
12,130
-2,394
| -16% | -$184K | 0.05% | 335 |
|
|
2022
Q1 | $1.13M | Sell |
14,524
-6,516
| -31% | -$517K | 0.05% | 324 |
|
|
2021
Q4 | $1.7M | Buy |
21,040
+41
| +0.2% | +$3.33K | 0.06% | 279 |
|
|
2021
Q3 | $1.72M | Buy |
20,999
+4,463
| +27% | +$367K | 0.07% | 269 |
|
|
2021
Q2 | $1.36M | Sell |
16,536
-7,120
| -30% | -$586K | 0.05% | 297 |
|
|
2021
Q1 | $1.95M | Sell |
23,656
-1,749
| -7% | -$144K | 0.05% | 294 |
|
|
2020
Q4 | $1.35M | Buy |
25,405
+11,019
| +77% | +$913K | 0.05% | 286 |
|
|
2020
Q3 | $1.19M | Sell |
14,386
-4,971
| -26% | -$413K | 0.06% | 262 |
|
|
2020
Q2 | $1.61M | Buy |
19,357
+9,932
| +105% | +$821K | 0.09% | 216 |
|
|
2020
Q1 | $770K | Buy |
9,425
+1,193
| +14% | +$96.9K | 0.05% | 295 |
|
|
2019
Q4 | $663K | Buy |
8,232
+49
| +0.6% | +$3.96K | 0.04% | 385 |
|
|
2019
Q3 | $660K | Buy |
8,183
+2,339
| +40% | +$189K | 0.04% | 353 |
|
|
2019
Q2 | $470K | Buy |
5,844
+1,456
| +33% | +$116K | 0.03% | 422 |
|
|
2019
Q1 | $349K | Buy |
4,388
+369
| +9% | +$29.1K | 0.02% | 494 |
|
|
2018
Q4 | $315K | Buy |
4,019
+400
| +11% | +$31.2K | 0.02% | 473 |
|
|
2018
Q3 | $282K | Buy |
3,619
+410
| +13% | +$32K | 0.02% | 533 |
|
|
2018
Q2 | $250K | Sell |
3,209
-851
| -21% | -$66.5K | 0.02% | 504 |
|
|
2018
Q1 | $318K | Sell |
4,060
-107
| -3% | -$8.41K | 0.03% | 404 |
|
|
2017
Q4 | $329K | Sell |
4,167
-3,147
| -43% | -$250K | 0.03% | 403 |
|
|
2017
Q3 | $583K | Sell |
7,314
-14,441
| -66% | -$1.15M | 0.06% | 278 |
|
|
2017
Q2 | $1.74M | Buy |
21,755
+1,058
| +5% | +$84.5K | 0.18% | 128 |
|
|
2017
Q1 | $1.65M | Buy |
20,697
+3,815
| +23% | +$304K | 0.17% | 125 |
|
|
2016
Q4 | $1.34M | Sell |
16,882
-404
| -2% | -$32.3K | 0.18% | 127 |
|
|
2016
Q3 | $1.4M | Sell |
17,286
-403
| -2% | -$32.6K | 0.19% | 126 |
|
|
2016
Q2 | $1.43M | Sell |
17,689
-7,351
| -29% | -$592K | 0.21% | 113 |
|
|
2016
Q1 | $2.02M | Buy |
+25,040
| New | +$2.01M | 0.31% | 79 |
|
Other funds holding BSV
AF
Geneos Wealth Management's BSV Position: Q2 2026 in Review
Geneos Wealth Management increased its Vanguard Short-Term Bond ETF (BSV) stake by 1.4% in Q2 2026, buying an estimated $40.5K and bringing the position to 37,741 shares worth $2.94M. The position accounts for 0.06% of the portfolio, ranked #318.
Geneos Wealth Management first reported a position in BSV in Q1 2016 and has held it in 42 quarters since. The position peaked at $10.1M in Q1 2025. 1,352 funds tracked by Wall St. Rank hold BSV as of Q2 2026.
- Geneos Wealth Management held 37,741 shares of Vanguard Short-Term Bond ETF worth $2.94M as of Q2 2026.
- Geneos Wealth Management bought 519 Vanguard Short-Term Bond ETF shares in Q2 2026, an estimated $40.5K.
- Vanguard Short-Term Bond ETF made up 0.06% of Geneos Wealth Management's portfolio in Q2 2026, its #318 holding.
- Geneos Wealth Management first reported a position in Vanguard Short-Term Bond ETF in Q1 2016 and has held it in 42 quarters since.
- Geneos Wealth Management's Vanguard Short-Term Bond ETF position peaked at $10.1M in Q1 2025.
- 1,352 funds tracked by Wall St. Rank held Vanguard Short-Term Bond ETF as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.